winchpharma (consumer healthcare) ltd
winchpharma (consumer healthcare) ltd Company Information
Company Number
08192249
Next Accounts
Dec 2025
Shareholders
byotrol plc
Group Structure
View All
Industry
Wholesale of pharmaceutical goods
+3Registered Address
building 303 (c/o byotrol plc), thornton science park, chester, CH2 4NU
Website
www.winchpharma.comwinchpharma (consumer healthcare) ltd Estimated Valuation
Pomanda estimates the enterprise value of WINCHPHARMA (CONSUMER HEALTHCARE) LTD at £23.8k based on a Turnover of £47.1k and 0.51x industry multiple (adjusted for size and gross margin).
winchpharma (consumer healthcare) ltd Estimated Valuation
Pomanda estimates the enterprise value of WINCHPHARMA (CONSUMER HEALTHCARE) LTD at £0 based on an EBITDA of £-126 and a 3.27x industry multiple (adjusted for size and gross margin).
winchpharma (consumer healthcare) ltd Estimated Valuation
Pomanda estimates the enterprise value of WINCHPHARMA (CONSUMER HEALTHCARE) LTD at £22.9k based on Net Assets of £10.9k and 2.1x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Winchpharma (consumer Healthcare) Ltd Overview
Winchpharma (consumer Healthcare) Ltd is a live company located in chester, CH2 4NU with a Companies House number of 08192249. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in August 2012, it's largest shareholder is byotrol plc with a 100% stake. Winchpharma (consumer Healthcare) Ltd is a established, micro sized company, Pomanda has estimated its turnover at £47.1k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Winchpharma (consumer Healthcare) Ltd Health Check
Pomanda's financial health check has awarded Winchpharma (Consumer Healthcare) Ltd a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 6 areas for improvement. Company Health Check FAQs
1 Strong
2 Regular
6 Weak
Size
annual sales of £47.1k, make it smaller than the average company (£23.5m)
- Winchpharma (consumer Healthcare) Ltd
£23.5m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Winchpharma (consumer Healthcare) Ltd
- - Industry AVG
Production
with a gross margin of 19.6%, this company has a higher cost of product (32.8%)
- Winchpharma (consumer Healthcare) Ltd
32.8% - Industry AVG
Profitability
an operating margin of -0.3% make it less profitable than the average company (5.9%)
- Winchpharma (consumer Healthcare) Ltd
5.9% - Industry AVG
Employees
with 1 employees, this is below the industry average (57)
- Winchpharma (consumer Healthcare) Ltd
57 - Industry AVG
Pay Structure
on an average salary of £57.3k, the company has an equivalent pay structure (£57.3k)
- Winchpharma (consumer Healthcare) Ltd
£57.3k - Industry AVG
Efficiency
resulting in sales per employee of £47.1k, this is less efficient (£466k)
- Winchpharma (consumer Healthcare) Ltd
£466k - Industry AVG
Debtor Days
it gets paid by customers after 108 days, this is later than average (58 days)
- Winchpharma (consumer Healthcare) Ltd
58 days - Industry AVG
Creditor Days
its suppliers are paid after 29 days, this is close to average (32 days)
- Winchpharma (consumer Healthcare) Ltd
32 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Winchpharma (consumer Healthcare) Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Winchpharma (consumer Healthcare) Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 21.9%, this is a lower level of debt than the average (46.7%)
21.9% - Winchpharma (consumer Healthcare) Ltd
46.7% - Industry AVG
WINCHPHARMA (CONSUMER HEALTHCARE) LTD financials
Winchpharma (Consumer Healthcare) Ltd's latest turnover from March 2024 is estimated at £47.1 thousand and the company has net assets of £10.9 thousand. According to their latest financial statements, we estimate that Winchpharma (Consumer Healthcare) Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 33,699 | 47,604 | 49,826 | 2,115 | ||||||||
| Other Income Or Grants | ||||||||||||
| Cost Of Sales | -1,886 | 25,780 | 39,408 | 51,237 | 1,492 | |||||||
| Gross Profit | 1,886 | 7,919 | 8,196 | -1,411 | 623 | |||||||
| Admin Expenses | 1,039 | -2,500 | 3,646 | 2,395 | 745 | |||||||
| Operating Profit | 847 | 10,419 | 4,550 | -3,806 | -122 | |||||||
| Interest Payable | 58 | 72 | ||||||||||
| Interest Receivable | ||||||||||||
| Pre-Tax Profit | 789 | 10,347 | 4,550 | -3,808 | -122 | |||||||
| Tax | ||||||||||||
| Profit After Tax | 789 | 10,347 | 4,550 | -3,808 | -122 | |||||||
| Dividends Paid | ||||||||||||
| Retained Profit | 789 | 10,347 | 4,550 | -3,808 | -122 | |||||||
| Employee Costs | ||||||||||||
| Number Of Employees | ||||||||||||
| EBITDA* | 847 | 10,419 | 4,550 | -3,806 | -122 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 762 | 1,649 | 1,546 | |||||||||
| Intangible Assets | ||||||||||||
| Investments & Other | ||||||||||||
| Debtors (Due After 1 year) | ||||||||||||
| Total Fixed Assets | 762 | 1,649 | 1,546 | |||||||||
| Stock & work in progress | 333 | 3,438 | 2,212 | 33,517 | 6,319 | 9,584 | ||||||
| Trade Debtors | 13,984 | 14,110 | 14,236 | 11,257 | 13,344 | 2,538 | 16,680 | 52,098 | 18,245 | 216 | ||
| Group Debtors | 2,805 | |||||||||||
| Misc Debtors | 18,747 | |||||||||||
| Cash | 14,823 | 16,252 | 3,978 | 20,509 | 3,781 | 13,390 | 28 | |||||
| misc current assets | ||||||||||||
| total current assets | 13,984 | 14,110 | 14,236 | 14,823 | 16,585 | 21,478 | 54,812 | 2,538 | 53,978 | 71,807 | 27,829 | 244 |
| total assets | 13,984 | 14,110 | 14,236 | 14,823 | 16,585 | 21,478 | 54,812 | 2,538 | 54,740 | 73,456 | 29,375 | 244 |
| Bank overdraft | ||||||||||||
| Bank loan | ||||||||||||
| Trade Creditors | 3,066 | 3,066 | 3,066 | 258 | 237 | 168,400 | 161,016 | 51,716 | 1,089 | |||
| Group/Directors Accounts | 15,105 | 2,659 | ||||||||||
| other short term finances | ||||||||||||
| hp & lease commitments | ||||||||||||
| other current liabilities | 3,066 | 5,359 | 5,515 | 58,741 | ||||||||
| total current liabilities | 3,066 | 3,066 | 3,066 | 3,066 | 5,617 | 20,857 | 58,741 | 2,659 | 168,400 | 161,016 | 51,716 | 1,089 |
| loans | ||||||||||||
| hp & lease commitments | ||||||||||||
| Accruals and Deferred Income | ||||||||||||
| other liabilities | 15,573 | |||||||||||
| provisions | ||||||||||||
| total long term liabilities | 15,573 | |||||||||||
| total liabilities | 3,066 | 3,066 | 3,066 | 3,066 | 5,617 | 20,857 | 58,741 | 2,659 | 183,973 | 161,016 | 51,716 | 1,089 |
| net assets | 10,918 | 11,044 | 11,170 | 11,757 | 10,968 | 621 | -3,929 | -121 | -129,233 | -87,560 | -22,341 | -845 |
| total shareholders funds | 10,918 | 11,044 | 11,170 | 11,757 | 10,968 | 621 | -3,929 | -121 | -129,233 | -87,560 | -22,341 | -845 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Operating Profit | 847 | 10,419 | 4,550 | -3,806 | -122 | |||||||
| Depreciation | 887 | 1,208 | 771 | |||||||||
| Amortisation | ||||||||||||
| Tax | ||||||||||||
| Stock | -333 | -3,105 | 1,226 | 2,212 | -33,517 | 27,198 | -3,265 | 9,584 | ||||
| Debtors | -126 | -126 | 14,236 | -14,062 | -18,029 | 29,553 | -14,142 | -35,418 | 33,853 | 18,029 | 216 | |
| Creditors | 3,066 | -258 | 21 | 237 | -168,400 | 7,384 | 109,300 | 50,627 | 1,089 | |||
| Accruals and Deferred Income | -3,066 | -2,293 | -156 | -53,226 | 58,741 | |||||||
| Deferred Taxes & Provisions | ||||||||||||
| Cash flow from operations | -1,371 | 27,451 | -31,636 | 23,170 | -120,863 | |||||||
| Investing Activities | ||||||||||||
| capital expenditure | ||||||||||||
| Change in Investments | ||||||||||||
| cash flow from investments | ||||||||||||
| Financing Activities | ||||||||||||
| Bank loans | ||||||||||||
| Group/Directors Accounts | -15,105 | 15,105 | -2,659 | 2,659 | ||||||||
| Other Short Term Loans | ||||||||||||
| Long term loans | ||||||||||||
| Hire Purchase and Lease Commitments | ||||||||||||
| other long term liabilities | -15,573 | 15,573 | ||||||||||
| share issue | ||||||||||||
| interest | -58 | -72 | ||||||||||
| cash flow from financing | -58 | -15,177 | 15,105 | -2,659 | 116,320 | |||||||
| cash and cash equivalents | ||||||||||||
| cash | -14,823 | -1,429 | 12,274 | -16,531 | 20,509 | -3,781 | -9,609 | 13,390 | -28 | 28 | ||
| overdraft | ||||||||||||
| change in cash | -14,823 | -1,429 | 12,274 | -16,531 | 20,509 | -3,781 | -9,609 | 13,390 | -28 | 28 |
winchpharma (consumer healthcare) ltd Credit Report and Business Information
Winchpharma (consumer Healthcare) Ltd Competitor Analysis
Perform a competitor analysis for winchpharma (consumer healthcare) ltd by selecting its closest rivals, whether from the MANUFACTURING sector, other micro companies, companies in CH2 area or any other competitors across 12 key performance metrics.
winchpharma (consumer healthcare) ltd Ownership
WINCHPHARMA (CONSUMER HEALTHCARE) LTD group structure
Winchpharma (Consumer Healthcare) Ltd has no subsidiary companies.
Ultimate parent company
1 parent
WINCHPHARMA (CONSUMER HEALTHCARE) LTD
08192249
winchpharma (consumer healthcare) ltd directors
Winchpharma (Consumer Healthcare) Ltd currently has 3 directors. The longest serving directors include Mr Christopher Sedwell (Jan 2022) and Mr Christopher Sedwell (Jan 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Christopher Sedwell | United Kingdom | 48 years | Jan 2022 | - | Director |
| Mr Christopher Sedwell | United Kingdom | 48 years | Jan 2022 | - | Director |
| Mr Ashley Head | England | 73 years | Aug 2024 | - | Director |
P&L
March 2024turnover
47.1k
+1%
operating profit
-126
0%
gross margin
19.7%
-1.4%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
10.9k
-0.01%
total assets
14k
-0.01%
cash
0
0%
net assets
Total assets minus all liabilities
winchpharma (consumer healthcare) ltd company details
company number
08192249
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
46450 - Wholesale of perfume and cosmetics
46760 - Wholesale of other intermediate products
incorporation date
August 2012
age
13
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
building 303 (c/o byotrol plc), thornton science park, chester, CH2 4NU
Bank
BARCLAYS BANK PLC, BARCLAYS BANK PLC, BARCLAYS BANK PLC
Legal Advisor
-
winchpharma (consumer healthcare) ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to winchpharma (consumer healthcare) ltd.
winchpharma (consumer healthcare) ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for WINCHPHARMA (CONSUMER HEALTHCARE) LTD. This can take several minutes, an email will notify you when this has completed.
winchpharma (consumer healthcare) ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
